4588 · Growth
Oncolys BioPharma Inc.
Pharmaceutical · Stock price, valuation and financial results
View watchlist →Share prices may be delayed. Price date: 2026-11-02. Figures are provided for research and are not investment advice.
Market data
Share price¥7,910
Market capitalization¥231,696,556,000
P/E ratioData unavailable
P/B ratio58×
Dividend yield0%
Financials
Latest fiscal year: 2025
Revenue¥28,546,000
Operating income-¥2,024,068,000
Net income-¥2,058,049,000
Return on equity-51.45%
Equity ratio87.8%
Share price history
Historical prices reflect the available market data. Use the date shown with each quote.
191 trading days
2026-11-02Open 7,500High 8,130Low 7,430Close 7,910Volume 2,015,800
Drag to pan · scroll to zoom
Five-year financial history
| Fiscal year | Revenue | Operating income | Net income | Equity |
|---|---|---|---|---|
| 2025 | ¥28,546,000 | -¥2,024,068,000 | -¥2,058,049,000 | ¥3,999,969,000 |
| 2024 | ¥31,384,000 | -¥1,681,403,000 | -¥1,684,778,000 | ¥2,752,209,000 |
| 2023 | ¥63,038,000 | -¥1,929,986,000 | -¥1,938,505,000 | ¥1,474,097,000 |
| 2022 | ¥976,182,000 | Data unavailable | -¥1,148,938,000 | ¥2,159,269,000 |
| 2021 | ¥642,494,000 | Data unavailable | -¥1,615,439,000 | ¥3,593,992,000 |
J-KABU Score
PRO ONLY
11-factor stock score
Checking membership…
PRO ONLY
AI stock analysis
Checking membership…
Industry peers
Companies in the same sector, ordered by market capitalization. Compare the underlying dates before drawing conclusions.
| Company | P/E | P/B | Dividend yield | ROE |
|---|---|---|---|---|
| CHUGAI PHARMACEUTICAL CO.,LTD. (4519) | 25.95x | 5.67x | 1.93% | 21.42% |
| Takeda Pharmaceutical Company Limited (4502) | Data unavailable | 3.21x | 3.07% | -4.62% |
| Otsuka Holdings Co.,Ltd. (4578) | 17.18x | 2.11x | Data unavailable | 11.97% |
| DAIICHI SANKYO COMPANY,LIMITED (4568) | 20.6x | Data unavailable | 3.46% | 5.97% |
| Astellas Pharma Inc. (4503) | 15.78x | 2.54x | 3.11% | 15.94% |
| Shionogi & Co.,Ltd. (4507) | 18.73x | 2.96x | 2.51% | 8.24% |
Company names without a verified English form are shown in their registered Japanese form.